EMA Withdrawn: Trovan (trovafloxacin) — Pfizer Limited

View source ↗

Summary

The European Medicines Agency has withdrawn Trovan (trovafloxacin) from the market; the decision affects its use for bacterial infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Trovan (trovafloxacin)

Snippet

Status: Withdrawn. Therapeutic area: Bacterial Infections. MAH: Pfizer Limited. Decision date: 31/12/2009